CISD2 and hepatocellular carcinoma: Development of therapeutic agents that can bring about effective enhancement of expression of Cisd2 might have potential as a therapeutic strategy for the treatment of fatty liver diseases, thereby preventing subsequent malignant progression to cirrhosis and HCC.